musculoskeletal tumor
Conditions
Interventions
All procedures are performed under real-time CT fluoroscopic guidance. After the patient is placed on the CT couch in the supine, prone, or lateral position, cryoprobes are consecutively placed with 1
Sponsors
Department of Radiology, Mie University School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria of this study are as follows: musculoskeletal tumor measuring 5.0 cm or less without regard to pain; age of 20 years or more; Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, 2 or 3; adequate main organ function; and a life expectancy of 1 month or longer. Patients have either single tumor or multiple tumors.
Exclusion criteria
Exclusion criteria: Exclusion criteria is an abnormal coagulability as defined by platelet count of less than 50,000/mm3, and an international normalized ratio (INR) of greater than 1.5.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint is safety that is evaluated by Common Terminology Criteria for Adverse Events (CTCAE ver 4.0). | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary endpoints are changes in visual analogue scale (VAS) score, tumor response, and survival. | — |
Countries
Japan
Contacts
Public ContactKoichiro Yamakado
Mie University School of Medicine Department of Radiology
Outcome results
None listed